Besides the differences in KIT mutational status between these IM-resistant GIST cell lines, both of them exhibited similar levels of phospho-KIT/c-KIT and FGFR2, as well (Supplementary Figure S6). This evidence concerns the gene FGFR2 and gastrointestinal stromal tumor.